• LACTB Drives Mitochondrial Remodeling to Promote Apoptosis

  2026-06-29

  The reference study reveals that the tumor suppressor LACTB directly remodels the inner mitochondrial membrane (IMM) to facilitate cytochrome c release and apoptosis. This work uncovers a previously unappreciated mechanism for IMM remodeling during programmed cell death, with implications for cancer therapy targeting mitochondrial pathways.

• Homoharringtonine Enables Rapid SARS-CoV-2 Clearance In Vivo

  2026-06-29

  A recent study demonstrates that homoharringtonine, a plant-derived cytotoxic alkaloid, can rapidly clear SARS-CoV-2 from the upper respiratory tract in both animal models and human pilot trials. This work establishes protein synthesis inhibition as a promising strategy for first-line intervention against coronaviruses and provides a foundation for future translational research.

• Gemcitabine in Cancer Research: Protocols, Insights, and Inn

  2026-06-28

  Gemcitabine, a potent DNA synthesis inhibitor, is a linchpin in translational cancer research and apoptosis assay development. This article details experimental workflows, troubleshooting strategies, and practical innovations that maximize its anti-tumor potential, with actionable guidance drawn from recent advances in pancreatic cancer and beyond.

• Dynasore in Translational Endocytosis Research: Mechanism to

  2026-06-27

  This thought-leadership article explores the strategic use of Dynasore, a potent dynamin GTPase inhibitor, in advancing mechanistic and translational endocytosis research. Bridging rigorous mechanistic insights with actionable guidance, it contextualizes recent discoveries—such as the role of clathrin-mediated endocytosis in Spiroplasma eriocheiris infection in Drosophila S2 cells—and provides protocol recommendations for experimentalists. Competitive context, clinical implications, and a forward-looking outlook are offered to empower researchers to leverage Dynasore for high-impact biological and disease-modeling studies.

• gamma-Glu-Cys (γ-Glu-Cys): Technical Guidance for Lab Workfl

  2026-06-26

  gamma-Glu-Cys (γ-Glu-Cys) provides a reliable, high-purity substrate essential for studies of glutathione metabolism and thiol-reactive peptide synthesis. Researchers benefit from its defined solubility and stability profile, enabling precise enzyme assays and plant stress adaptation experiments. This reagent is not suitable for diagnostic, medical, or in vivo applications.

• MCC950 Sodium in NLRP3 Inflammasome Research: Applied Workfl

  2026-06-26

  MCC950 sodium (CRID3 sodium salt) delivers nanomolar, selective NLRP3 inflammasome inhibition, enabling precise investigation of inflammatory and autoimmune disease mechanisms. This article distills cutting-edge experimental strategies, protocol optimizations, and troubleshooting insights—anchored by recent bench research—for reliable, reproducible results.

• Meropenem Trihydrate in Resistance Studies: Protocols & Insi

  2026-06-25

  Meropenem trihydrate stands out as a benchmark carbapenem antibiotic for investigating resistance mechanisms and optimizing infection model workflows. This article delivers actionable guidance for experimental design, troubleshooting, and leveraging metabolomics, empowering researchers to translate molecular insight into robust, reproducible data.

• JHU-083: 6-diazo-5-oxo-L-norleucine Precursor in Neuro-Redox

  2026-06-25

  JHU-083, as a potent 6-diazo-5-oxo-L-norleucine precursor, enables selective glutaminase inhibition in cerebral CD11b cells, making it ideal for neuro-redox and glutamate excitotoxicity research. This guide details optimized workflows, troubleshooting strategies, and leverages cutting-edge findings to maximize assay precision in neurological disease models.

• Targeting Glutamine Metabolism in HSCs to Alleviate Liver Fi

  2026-06-24

  This study reveals that modulating glutamine metabolism, specifically through glutamate dehydrogenase (GDH) inhibition and sirtuin 4 (SIRT4) regulation, significantly reduces hepatic stellate cell (HSC) activation and attenuates liver fibrosis. These mechanistic insights provide a foundation for developing metabolic interventions in chronic liver disease research.

• 10 mM dNTP Mixture: Precision DNA Synthesis Reagent (K1041)

  2026-06-23

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture enables highly reproducible DNA polymerization in PCR, qPCR, and sequencing workflows. Its equimolar, pH-neutralized formulation ensures optimal enzyme compatibility and minimizes nucleotide imbalance, supporting reliable molecular biology applications.

• MMP-2-Responsive Peptide Nanoparticles Enhance Breast Cancer

  2026-06-23

  This study introduces an MMP-2-responsive, dual-drug-loaded peptide nanocarrier that transforms in the tumor microenvironment to improve drug targeting and retention. The approach enhances immunogenic cell death and immune response, showing promise for more effective breast cancer therapies.

• Optimizing Sulfaphenazole Analogs for TB: Reduced CYP2C9 Inh

  2026-06-22

  The referenced study systematically engineered sulfonamide derivatives of Sulfaphenazole to retain antimycobacterial activity against Mycobacterium tuberculosis while minimizing CYP2C9 inhibition. This research advances molecular design strategies for new TB agents with a lower risk of drug-drug interactions, providing a model for balancing efficacy and pharmacological safety.

• Protease Inhibitor Cocktail: Precision in Protein Extraction

  2026-06-22

  Protecting protein integrity is critical for reproducible cell signaling and oncology research. The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO delivers broad-spectrum, reliable inhibition of endogenous proteases, streamlining workflows for applications from Western blotting to advanced kinase assays.

• PD0325901: MEK Inhibitor Workflows for Tumor Suppression

  2026-06-21

  PD0325901 stands out as a selective MEK inhibitor, enabling precise RAS/RAF/MEK/ERK pathway modulation in cancer research. This article details advanced workflows, troubleshooting strategies, and data-driven insights to maximize experimental reliability and translational potential.

• Biotin-16-UTP: Technical Guidance for RNA Labeling Workflows

  2026-06-20

  Biotin-16-UTP provides a reliable reagent for site-specific biotin labeling of RNA during in vitro transcription, enabling downstream detection, purification, and interaction studies. It should be used where high-purity, stable, and reproducible RNA labeling is required, but may not be suitable for diagnostic or clinical purposes, or for workflows incompatible with biotin-streptavidin systems.

14881 records 1/993 page Next 12345 下5页 Last page